DT Midstream, Inc. · DTM · FY2026 Q1 · Calendar Q2 2026
DTM reaffirms guidance as project demand expands
DTM's Q1 call supports a constructive growth case built on contracted pipeline expansion, strong demand in Midwest and Northeast corridors, and data-center and power-generation load. The key test is whether projects reach FID and execution while regulatory, seasonal, and rate-related risks remain manageable.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about DTM FY2026 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter's analysis, management maintained rather than raised guidance, increased the 2026-27 capital budget to $400-$440 million, and added project detail around Vector, Millennium R2R, and an Indiana lateral. Oversubscribed open seasons and the NEXUS interconnect provided new evidence of demand, while extreme winter conditions were a material Q1 driver.
Guidance delta
Guidance was maintained. Management reaffirmed 2026 adjusted EBITDA guidance and kept the dividend at $0.88 per share; the call analysis also identified a $400-$440 million 2026-27 capital budget.
Key takeaways
- Q1 performance exceeded expectations with cold-weather demand and high asset utilization supporting results.
- Vector, Millennium R2R, and an Indiana lateral expand the project pipeline, with combined announced capacity additions exceeding 1 bcf/d.
- Oversubscribed Midwestern and Vector open seasons point to strong demand, but FID, regulatory approval, and execution remain important milestones.
Management priorities
- Advance Vector, Millennium R2R, and Indiana lateral projects.
- Expand LEAP capacity and continue open seasons to commercialize Midwest and Northeast projects.
- Fund growth within the balance sheet while maintaining the dividend.
Follow DTM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 1, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 21, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 6, 2026 |
| Jefferies | Buy | Buy | Maintain | Sep 16, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Sep 10, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 26, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Jul 31, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 8, 2026 |
| UBS | Buy | Buy | Maintain | May 15, 2026 |
| Citigroup | Buy | Buy | Maintain | May 4, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Apr 20, 2026 |
| Stifel | Hold | Buy | Downgrade | Feb 24, 2026 |
| B of A Securities | Buy | Buy | Maintain | Dec 11, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jan 28, 2025 |
| Credit Suisse | Neutral | Outperform | Downgrade | Mar 8, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $124.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Analyst unavailable | $150 | $119.09 | +20.6% | Oct 15, 2026 |
| Scotiabank | Analyst unavailable | $165 | $117.88 | +32.7% | Oct 15, 2026 |
| Goldman Sachs | John Mackay | $121 | $126.55 | -2.7% | Oct 14, 2026 |
| Barclays | Analyst unavailable | $142 | $122.12 | +14.2% | Oct 6, 2026 |
| Jefferies | Analyst unavailable | $145 | $125.08 | +16.6% | Sep 16, 2026 |
| Scotiabank | Analyst unavailable | $168 | $130.23 | +35.1% | Sep 10, 2026 |
| Wolfe Research | Keith Stanley | $145 | $126.74 | +16.6% | Aug 26, 2026 |
| Jefferies | Analyst unavailable | $155 | $136.77 | +24.7% | Jul 31, 2026 |
| Jefferies | Analyst unavailable | $170 | $145.29 | +36.7% | Jul 16, 2026 |
| Jefferies | Julien Dumoulin-Smith | $164 | $146.72 | +31.9% | Jul 8, 2026 |
| Scotiabank | Analyst unavailable | $176 | $151.12 | +41.5% | May 26, 2026 |
| Morgan Stanley | Robert Kad | $170 | $144.44 | +36.7% | May 12, 2026 |
| Jefferies | Julien Dumoulin-Smith | $166 | $147.99 | +33.5% | May 1, 2026 |
| Barclays | Analyst unavailable | $143 | $147.99 | +15.0% | May 1, 2026 |
| Raymond James | Analyst unavailable | $158 | $147.99 | +27.1% | Apr 30, 2026 |
| Goldman Sachs | Analyst unavailable | $127 | $134.24 | +2.1% | Apr 20, 2026 |
| Stifel Nicolaus | Analyst unavailable | $137 | $137.91 | +10.2% | Feb 23, 2026 |
| Wells Fargo | Analyst unavailable | $150 | $136.06 | +20.6% | Feb 22, 2026 |
| UBS | Manav Gupta | $152 | $131.91 | +22.2% | Feb 20, 2026 |
| Jefferies | Analyst unavailable | $148 | $132.33 | +19.0% | Feb 20, 2026 |
| Mizuho Securities | Analyst unavailable | $129 | $133.21 | +3.7% | Feb 17, 2026 |
| Morgan Stanley | Robert Kad | $139 | $131.4 | +11.8% | Feb 10, 2026 |
| Jefferies | Analyst unavailable | $141 | $125.47 | +13.4% | Jan 30, 2026 |
| Barclays | Analyst unavailable | $119 | $118.19 | -4.3% | Jan 14, 2026 |
| Jefferies | Analyst unavailable | $125 | $109.49 | +0.5% | Nov 3, 2025 |
| Stifel Nicolaus | Analyst unavailable | $119 | $109.91 | -4.3% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $114 | $114.01 | -8.3% | Oct 8, 2025 |
| UBS | Analyst unavailable | $128 | $113.36 | +2.9% | Oct 3, 2025 |
| Mizuho Securities | Analyst unavailable | $108 | $104.14 | -13.1% | Aug 29, 2025 |
| Morgan Stanley | Robert Kad | $115 | $107.21 | -7.5% | Jun 3, 2025 |
| Williams Trading | Analyst unavailable | $110 | $101 | -11.5% | Mar 24, 2025 |
| Stifel Nicolaus | Selman Akyok | $89 | $89.3 | -28.4% | Oct 30, 2024 |
| Barclays | Q3 EBITDA | $85 | $81.48 | -31.6% | Oct 3, 2024 |
| Mizuho Securities | Robert Mosca | $72 | $74.22 | -42.1% | Jul 30, 2024 |
| Barclays | Theresa Chen | $72 | $71.1 | -42.1% | Jul 17, 2024 |
| Wells Fargo | Michael Blum | $77 | $66.86 | -38.1% | Jun 4, 2024 |
| Barclays | Theresa Chen | $66 | $63.42 | -46.9% | Apr 5, 2024 |
| Goldman Sachs | John MacKay | $46 | $52.43 | -63.0% | Feb 16, 2024 |
| Citigroup | Spiro Dounis | $54 | $50.45 | -56.6% | Jul 10, 2023 |
| Wells Fargo | Analyst unavailable | $62 | $54.9 | -50.1% | Dec 16, 2022 |
| Barclays | Analyst unavailable | $62 | $57.29 | -50.1% | Aug 16, 2022 |
| Mizuho Securities | Analyst unavailable | $58 | $53.89 | -53.4% | Aug 4, 2022 |
| Mizuho Securities | Analyst unavailable | $57 | $53.2 | -54.2% | May 10, 2022 |
| Wells Fargo | Analyst unavailable | $59 | $54.2 | -52.5% | Apr 28, 2022 |
| Morgan Stanley | Analyst unavailable | $60 | $54.77 | -51.7% | Apr 26, 2022 |
Track every rating change on DTM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationDT Midstream, Inc. is a U.S.-based company offering a comprehensive suite of natural gas infrastructure and related services. The organization's operations are divided into two primary divisions: Pipeline and Gathering. It is responsible for the development, ownership, and management of an interconnected network of assets. This portfolio includes both interstate and intrastate pipelines, natural gas storage facilities, lateral pipelines, gathering systems, specialized treatment plants, and various compression and surface equipment.…
Historical context
All DTM earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CVX Chevron Corporation | FY2026 Q3 · Calendar Q4 2026 | +8.4% | +1.8% | Chevron posts strong Q3 as production, cash flow and AI value rise |
| XOM Exxonmobil Holdings Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +2.2% | ExxonMobil Highlights Refining, LNG and Cash Returns in Q3 |
| IMO Imperial Oil Limited | FY2026 Q3 · Calendar Q4 2026 | +6.4% | +5.5% | Imperial Oil: downstream strength and low-carbon growth lead Q3 |
| CCJ Cameco Corporation | FY2026 Q3 · Calendar Q4 2026 | -101.4% | -7.9% | Cameco keeps nuclear-growth thesis intact as Key Lake outage weighs |
| BP BP p.l.c. | FY2026 Q3 · Calendar Q4 2026 | +22.6% | +0.1% | BP Q3: Strong profit, lower debt, safety risks persist |
| FSLR First Solar, Inc. | FY2026 Q3 · Calendar Q4 2026 | +13.5% | -1.4% | First Solar: Margin gains offset lower volume outlook |
Latest beats and misses
Who reports nextBeat on EPS
- CHDFY2026 Q3 · October 30, 2026+2.2% EPS+1.2% move
- AZNFY2026 Q3 · October 30, 2026+7.3% EPS+7.0% move
- FRTFY2026 Q3 · October 30, 2026+3.9% EPS-1.1% move
- CVXFY2026 Q3 · October 30, 2026+8.4% EPS+1.8% move
- BTSGFY2026 Q3 · October 30, 2026+14.2% EPS+11.1% move
- EXCFY2026 Q3 · October 30, 2026+10.4% EPS+0.5% move
Missed on EPS
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
- VALEFY2026 Q3 · October 29, 2026-24.6% EPS+1.9% move
- DLR-PLFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLR-PKFY2026 Q3 · October 29, 2026-8.4% EPS— move
Get the DTM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-01T09:30:40.222033+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-01T09:30:40.218998+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-01. For educational purposes only; not investment advice.